All Type of News
‘Cold wave’ of staff reduction in the pharmaceutical industry, having controversy for one-sided discharges
Staff reduction has spread in the pharmaceutical industry.
The layoff movement has been sensed among Korean branches of multinational pharmaceutical company. In particular, it expects controversy as some of them are ...
“Innovative pharmaceutical companies led pharmaceutical results in 2015”
While the growth of the pharmaceutical industry has stood out, innovative pharmaceutical companies were observed to contribute to the industry to draw results.
In addition, the total sales of the 20 innovative pharma...
Zuellig Pharma Korea, “We will help Korean pharmaceuticals to expand foreign markets”Zuellig Pharma Korea announced a position to provide help for innovative pharmaceutical products developed by domestic pharmaceutical companies to enter foreign markets.
In fac...
|
Fierce competition between Chong Kun Dang’s ‘Cemdom’ vs Hanmi Pharm’s ‘Gugu’In the ‘Cialis Generic’ competition, also known as the ‘Generic War’ among domestic pharmaceutical companies, Chong Kun Dang’s ‘Cendom’ and Hanmi Pharm’s ‘Gugu’ have created fie...
|
Korea Centers for Disease Control and Prevention promoted to the vice-minister class in 2016
The Korea Centers for Disease Control and Prevention will be promoted to the vice-minister class in 2016.
The Ministry of Health and Welfare(Minister Jin-yup Jung) announced the enforcement of promoting the Korea Cen...
A series of pharmaceutical companies deciding free issue of new shares, spreading shareholder-friendly policy
The dividend payment season has come. Like the last year, pharmaceutical companies have the shareholder-friendly policy, which set the profit-sharing of shareholders as the key value.
In particular, as the number of ...
Average annual growth rate of pharmaceutical manufacturing is 4.98% in 10 years
For the past 10 years, the average annual growth rate of pharmaceutical manufacturing volume was observed to be 4.98%. Although the average annual growth rate of imports was 7.59%, the one of exports was 13.4%, which ...
Chong Kun Dang announces domestic exclusive sales agreement of lupus treatmentOn the 14th, Chong Kun Dang(CEO Young-joo Kim) announced the domestic exclusive sales agreement of ‘IFN-K(interferenon-α-kinoid), a systemic lupus erythematosus(hereinafter refe...
|
‘Azilect,’ Parkinson’s disease treatment, lands in Big 5 hospitals
A treatment, which was newly launched in 10 years in the Parkinson’s disease treatment market, has been safely settled in the ‘Big 5’ hospitals.
According to the healthcare industry on the 15th, ‘Azilect(generic name...
‘Velcade Inj,’ soon to be expired in patent, attracts interests of 3 companies, such as Chong Kun Dang
Expiring on the 28th, the patent of ‘Velcade Inj(generic name: bortezomib),’ a Janssen Korea’s multiple myeloma treatment, has attracted attention of domestic pharmaceutical companies.
According to the Ministry of Fo...
